Publication | Closed Access

Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice

Recombinant Dense GranuleAutoimmune DiseaseAllergyImmunologyAntigen ProcessingAutoimmunityHumoral ImmunityImmunotherapeuticsImmunosuppressionImmunotherapyMedicineProtective EffectToxoplasma Chronic Infection